NOVEXEL
Novexel is a pharmaceutical company that researches and develops novel class antiinfectives for the treatment of severe and difficult to treat bacterial and fungal infections. The Company has an extensive portfolio of antibacterial and anti-fungal compounds, R&D programs, and intellectual property. Novexel’s focus is on novel antimicrobial compounds with activity against multi-resistantorganisms. Novexel’s expertise in Biology, Medicinal Chemistry, Pharmacology, Microbiology and Clinical Development positions the Company at the forefront of the discovery and development of novel therapies for infectious disease.
NOVEXEL
Social Links:
Industry:
Biotechnology Health Care Medical
Founded:
2004-01-01
Address:
Romainville, Ile-de-France, France
Country:
France
Website Url:
http://www.novexel.com
Total Employee:
1+
Status:
Active
Contact:
33 1 57 14 07 77
Email Addresses:
[email protected]
Total Funding:
118.62 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible LetsEncrypt Content Delivery Network Euro Amazon PHP OpenResty CPanel AdBlock Acceptable Ads
Similar Organizations
Peptor
A biopharmaceutical company engaged in discovery and development of immunotherapeutic drugs to treat diabetes
Current Advisors List
Current Employees Featured
Founder
Investors List
NIF SMBC Ventures
NIF SMBC Ventures investment in Series B - Novexel
Atlas Venture
Atlas Venture investment in Series B - Novexel
Goldman Sachs Investment Partners
Goldman Sachs Investment Partners investment in Series B - Novexel
Novo Ventures
Novo Ventures investment in Series B - Novexel
Neomed Management
Neomed Management investment in Series B - Novexel
Andera Partners
Andera Partners investment in Series B - Novexel
Abingworth
Abingworth investment in Series B - Novexel
Sofinnova Investments
Sofinnova Investments investment in Series B - Novexel
3i Group
3i Group investment in Series B - Novexel
Sofinnova Investments
Sofinnova Investments investment in Series A - Novexel
Official Site Inspections
http://www.novexel.com
- Host name: a2b7bf3398455f345.awsglobalaccelerator.com
- IP address: 99.83.161.153
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "Novexel"
Novexel - Crunchbase Company Profile & Funding
Novexel’s focus is on novel antimicrobial compounds with activity against multi …See details»
Novexel Company Profile - Office Locations, Competitors ... - Craft
See insights on Novexel including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Novoxel
Novoxel® was founded in 2011 with the vision to revolutionize fractional skin rejuvenation by creating new and better types of treatments for physicians and …See details»
Novexel 2025 Company Profile: Valuation, Investors, …
Information on acquisition, funding, cap tables, investors, and executives for Novexel. Use the PitchBook Platform to explore the full profile.See details»
Novexel — Sofinnova Partners
Novexel was acquired by AstraZeneca in 2010 for more than $500 million. Novexel was an emerging specialty pharmaceutical company focused on the …See details»
Novexel - Company Profile - Tracxn
Jun 13, 2025 Novexel - Developer of antibacterial and antifungal agents to treat bacterial and fungal infections. Acquired by Astrazeneca. Raised a total funding of $119M over 2 rounds …See details»
Novexel - Products, Competitors, Financials, Employees, …
Novexel specializes in antimicrobial research and development, particularly in the areas of antibacterial and antifungal treatments. The company focuses on the discovery and …See details»
Novexel SA - Drug pipelines, Patents, Clinical trials - Synapse
May 7, 2025 Explore Novexel SA with its drug pipeline, therapeutic area, technology platform, 2 clinical trials, 1 news, Drug:Viquidacin, NXL-105, Flopristin/Linopristin, NXL-102.See details»
novexel.com
See relevant content for novexel.comContent blocked Please turn off your ad blocker.See details»
Novexel Company Profile | Management and Employees List
Novexel Profile and History Novexel is a rapidly developing specialty pharmaceutical company focused exclusively on the discovery development and commercialization of novel antibiotics, …See details»
Organization | Novexel Inc
Novexel Inc Report issue Contributed to NME For profit Phase 2 Founded: Romainville France (2004) Status: Acquired by AstraZeneca (2009)See details»
Novexel - Financial Details - Crunchbase
Novexel SA, a pharmaceutical company, engages in the discovery and development of antibacterial and antifungal agents to treat bacterialSee details»
Innovaxel: Software Development & Technology Consulting
Innovaxel is a software development company that helps businesses thrive in the digital age. We offer technology consulting, software development, and team augmentation services to help …See details»
Novexel - Romainville, France
Novexel is a speciality pharmaceutical company focused on the discovery and development of novel anti-bacterials designed to overcome the significant global problem of bacterial …See details»
Novexel: Contact Details and Business Profile - RocketReach
Novexel is a Biotechnology Research, Manufacturing General, and Biotechnology company_reader located in Romainville, Ile-de-France with $5 million in revenue and 5 …See details»
Novexel - Company Profile & Staff Directory | ContactOut
Novexel SA, a pharmaceutical company, engages in the discovery and development of antibacterial and antifungal agents to treat bacterial and fungal infections. The company …See details»
Novexel SA - Company Profile and News - Bloomberg Markets
Company profile page for Novexel SA including stock price, company news, executives, board members, and contact informationSee details»
Novexel SA – Funding, Valuation, Investors, News
Novexel – Acquired by AstraZeneca in 2010 for more than $500 million. Novexel is an emerging specialty pharmaceutical company focused on the discovery and development of novel …See details»
AstraZeneca To Acquire Infection Research Company Novexel And …
Dec 23, 2009 AstraZeneca announced today that it has entered into an agreement to acquire Novexel, a private infection research company in France, and will collaborate with Forest …See details»
Novexel SA - VentureRadar
Anti-infectious drug development ... Find out more about Novexel SA, Life Sciences and Healthcare, Life sciences, Drug Development, Biopharmaceuticals, Healthtech and Life …See details»